Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11637474 | PMC |
| http://dx.doi.org/10.1093/rheumatology/keae211 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Novel Approach to Early Personalized Hemodynamic Resuscitation: Non-Invasive Peripheral Photoplethysmography for Identifying Predominant Vasodilatory Shock in Sepsis.
Acta Anaesthesiol Scand
October 2025
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Introduction: Sepsis remains a leading cause of mortality, with mortality from septic shock exceeding 40%. Standardized resuscitation (30 mL/kg) may cause adverse outcomes, including fluid overload or prolonged hypotension, emphasizing the need for individualized strategies. Sepsis-induced shock arises from varying degrees of vasodilation and hypovolemia, yet patients often present with similar clinical signs in the emergency department (ED).
View Article and Find Full Text PDFAn evaluation of zanidatamab, a novel, anti-HER2 biparatopic antibody, for the treatment of biliary tract cancer.
Expert Opin Biol Ther
September 2025
Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Introduction: Zanidatamab is a humanized biparatopic IgG antibody that selectively inhibits HER2 signaling pathway by targeting two distinct epitopes in the extracellular domains II and IV of HER2. Zanidatamab received accelerated approval from the United States Food and Drug Administration for the treatment of HER2-positive (immunohistochemistry [IHC] 3+) biliary tract cancer (BTC) in November 2024. Additionally, zanidatamab received approval for the treatment of HER2 IHC 3+ BTC from the European Medicines Agency in June 2025, and from National Medical Products Administration of China in May 2025.
View Article and Find Full Text PDFPerioperative Risk Prediction in Head and Neck Free Flap Reconstructive Surgery.
Acta Anaesthesiol Scand
October 2025
Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Background: Extensive head and neck reconstructive surgery is a complex procedure often performed in patients with multiple comorbidities, and the risk of complications is high. Evidence-based preoperative assessment and reliable risk prediction are therefore essential, and the anesthesiologist plays an important role in this process. The aim of this study was to evaluate the predictive properties of readily available clinical parameters for postoperative complications.
View Article and Find Full Text PDFComment on 'Early Initiation of Hydroxychloroquine in Cutaneous Lupus Erythematosus to Prevent Progression to Systemic Lupus Erythematosus: A Long-term Follow-up Study'.
J Am Acad Dermatol
August 2025
Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China. Electronic address:
Comment on: 'presentation of a novel method to estimate analog mean systemic filling pressure based on cardiac power' -on correlation, coupling, and physiological meaning.
J Clin Monit Comput
August 2025
Departamento de Medicina Intensiva, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago Centro, Chile.
In response to the recent proposal by Monares-Zepeda et al. to estimate mean systemic filling pressure (MSFP) using cardiac power (CP) as a surrogate for the venous return pressure gradient (VRg), we raise concerns regarding the physiological validity and generalizability of the reported correlation. We demonstrate through simulation that the relationship between CP and VRg arises from structural mathematical coupling due to shared dependence on cardiac output (CO), and that this correlation weakens significantly (r = 0.
View Article and Find Full Text PDF